NSABP B-59

NSABP Foundation, Inc. / “A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negative Breast Cancer Followed by Adjuvant Continuation of Atezolizumab or Placebo”

What We’ve Been Up to Lately

Our research team was recently awarded with the Gold Certificate of Excellence by the NCI Community Oncology Research Program. This award is given to research teams who are able to enroll a specified number of patients onto NCI sponsored clinical trials within a certain time period. Our team is one of 43 total to have been given this award so far this year. We would not have been able to earn this award without the help of our wonderful patients and is a testament to them!